down arrow

Zydus Lifesci.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE010B01027
  • NSEID: ZYDUSLIFE
  • BSEID: 532321
INR
869.00
24.4 (2.89%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 7.82 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

855.15876.95

52 Week

797.051,323.90
Valuation
Technical
Day's Volume

CASH

7.82 lacs (-55.96%) Volume

Shareholding (Dec 2024)

FII

7.53%

Held by 624 FIIs

DII

10.65%

Held by 41 DIIs

Promoter

74.98%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

High Management Efficiency with a high ROE of 19.00%

 
2

Company has a low Debt to Equity ratio (avg) at 0 times

 
3

Healthy long term growth as Operating profit has grown by an annual rate 22.23%

 
4

The company has declared Positive results for the last 7 consecutive quarters

5

Stock is technically in a Bearish range

6

With ROE of 19.6, it has a Attractive valuation with a 3.9 Price to Book Value

7

Majority shareholders : Promoters

 
8

Underperformed the market in the last 1 year

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 87,442 Cr (Large Cap)

stock-summary
P/E

19.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.36%

stock-summary
Debt Equity

-0.11

stock-summary
Return on Equity

19.63%

stock-summary
Price to Book

3.89

Revenue and Profits (1 Year):
Net Sales:
5,269 Cr
(Quarterly Results - Dec 2024)
Net Profit:
1,024 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.36%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-18.34%
0%
-18.34%
1 Year
-12.58%
0.30%
-12.28%
2 Years
73.52%
1.71%
75.23%
3 Years
133.7%
3.44%
137.14%
4 Years
68.89%
2.45%
71.34%
5 Years
147.79%
4.33%
152.12%

Latest dividend: 3 per share ex-dividend date: Jul-26-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
9.66%
EBIT Growth (5y)
22.23%
EBIT to Interest (avg)
31.35
Debt to EBITDA (avg)
0.98
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.86
Tax Ratio
22.20%
Dividend Payout Ratio
7.82%
Pledged Shares
0
Institutional Holding
18.18%
ROCE (avg)
18.02%
ROE (avg)
19.00%
Valuation key factors
Factor
Value
P/E Ratio
19
Industry P/E
33
Price to Book Value
3.89
EV to EBIT
14.56
EV to EBITDA
12.60
EV to Capital Employed
4.24
EV to Sales
3.72
PEG Ratio
0.55
Dividend Yield
0.36%
ROCE (Latest)
27.81%
ROE (Latest)
19.63%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 31 Schemes (6.32%)

FIIs

Held by 624 FIIs (7.53%)

Promoter with highest holding

Zydus Family Trust (pankaj R. Patel, Pritiben P. Patel And Sharvil P. Patel-trustees) (74.96%)

Highest Public shareholder

Llife Insurance Corporation Of India (3.53%)

Individual Investors Holdings

5.47%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 16.96% vs 5.83% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 29.62% vs 26.76% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,269.10",
          "val2": "4,505.20",
          "chgp": "16.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,387.60",
          "val2": "1,102.40",
          "chgp": "25.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "32.00",
          "val2": "19.80",
          "chgp": "61.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.30",
          "val2": "21.80",
          "chgp": "-101.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,023.50",
          "val2": "789.60",
          "chgp": "29.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "27.08%",
          "val2": "25.38%",
          "chgp": "1.70%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 20.36% vs 15.85% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 23.50% vs 81.36% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "11,444.50",
          "val2": "9,508.40",
          "chgp": "20.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,545.40",
          "val2": "2,651.40",
          "chgp": "33.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "57.30",
          "val2": "26.80",
          "chgp": "113.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.30",
          "val2": "-16.20",
          "chgp": "101.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,331.10",
          "val2": "1,887.60",
          "chgp": "23.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "31.77%",
          "val2": "28.47%",
          "chgp": "3.30%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 19.27% vs 12.43% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 25.30% vs 60.92% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "16,713.60",
          "val2": "14,013.60",
          "chgp": "19.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4,933.00",
          "val2": "3,753.80",
          "chgp": "31.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "89.30",
          "val2": "46.60",
          "chgp": "91.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "5.60",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3,354.60",
          "val2": "2,677.20",
          "chgp": "25.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "29.51%",
          "val2": "26.79%",
          "chgp": "2.72%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 13.40% vs 14.08% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 96.88% vs -56.31% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "19,547.40",
          "val2": "17,237.40",
          "chgp": "13.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5,384.30",
          "val2": "3,859.90",
          "chgp": "39.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "81.20",
          "val2": "129.90",
          "chgp": "-37.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "8.80",
          "val2": "-608.80",
          "chgp": "101.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3,859.50",
          "val2": "1,960.30",
          "chgp": "96.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "28.31%",
          "val2": "22.87%",
          "chgp": "5.44%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
5,269.10
4,505.20
16.96%
Operating Profit (PBDIT) excl Other Income
1,387.60
1,102.40
25.87%
Interest
32.00
19.80
61.62%
Exceptional Items
-0.30
21.80
-101.38%
Consolidate Net Profit
1,023.50
789.60
29.62%
Operating Profit Margin (Excl OI)
27.08%
25.38%
1.70%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 16.96% vs 5.83% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is 29.62% vs 26.76% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
11,444.50
9,508.40
20.36%
Operating Profit (PBDIT) excl Other Income
3,545.40
2,651.40
33.72%
Interest
57.30
26.80
113.81%
Exceptional Items
0.30
-16.20
101.85%
Consolidate Net Profit
2,331.10
1,887.60
23.50%
Operating Profit Margin (Excl OI)
31.77%
28.47%
3.30%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 20.36% vs 15.85% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 23.50% vs 81.36% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
16,713.60
14,013.60
19.27%
Operating Profit (PBDIT) excl Other Income
4,933.00
3,753.80
31.41%
Interest
89.30
46.60
91.63%
Exceptional Items
0.00
5.60
-100.00%
Consolidate Net Profit
3,354.60
2,677.20
25.30%
Operating Profit Margin (Excl OI)
29.51%
26.79%
2.72%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 19.27% vs 12.43% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 25.30% vs 60.92% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
19,547.40
17,237.40
13.40%
Operating Profit (PBDIT) excl Other Income
5,384.30
3,859.90
39.49%
Interest
81.20
129.90
-37.49%
Exceptional Items
8.80
-608.80
101.45%
Consolidate Net Profit
3,859.50
1,960.30
96.88%
Operating Profit Margin (Excl OI)
28.31%
22.87%
5.44%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 13.40% vs 14.08% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 96.88% vs -56.31% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Zydus Lifesciences Ltd stock-summary
stock-summary
Zydus Lifesciences Ltd
Large Cap
Pharmaceuticals & Drugs
Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain including innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), Active Pharmaceutical Ingredients (APIs), animal healthcare products and consumer well
Company Coordinates stock-summary
Company Details
Zydus Corporate Park S No 536, Khoraj Sarkhej-Gandhinagar H/W Ahmedabad Gujarat : 382481
stock-summary
Tel: 91-079-26868100
stock-summary
http://www.zyduscadila.com
stock-summary
upen.shah@zyduscadila.com
Registrar Details
Sharepro Services (India) Pvt Ltd, 13A/B 2nd Floor, Samitha Warehousing Complex, Behind Sakinaka Telephone Exchange, Andheri Kurla Road, Sakinaka, Andheri (East), Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."